Skip to content
The People's CodeSearch
Menu

H.R. 7482 · House bill · 119th Congress

LymeX Authorization Act

  1. Introduced
  2. In committeeEnergy and Commerce
  3. Passed the House (not yet)
  4. Passed the Senate (not yet)
  5. Law (not yet)

What it says

About this text

Text: , (the only version so far)

Official text on Congress.gov

This bill creates or directs, rather than amending the Code.

Its own words follow, as Congress.gov publishes them.

Sec. 1. Short title This Act may be cited as the LymeX Authorization Act.

Sec. 2. Policy It is the policy of the United States to—

(1) engage stakeholders, including academia, nonprofits, industry, small business, entrepreneurs, and government to facilitate patient-centered innovations in Lyme disease care;

(2) foster breakthroughs in health education and public awareness initiatives focused on Lyme disease patients; and

(3) accelerate development of next-gen diagnostics that are rapid and patient focused.

Sec. 3. Authorization of appropriations There is authorized to be appropriated to the Secretary of Health and Human Services $5,000,000 to carry out prize competitions (as defined in section 24 of the Stevenson-Wydler Technology Innovation Act of 1980 (15 U.S.C. 3719)) to accelerate innovation in the prevention, diagnosis, and treatment of Lyme disease.